Clinical trial
Phase II Randomized Trial:Arginine Butyrate Plus Standard Local Therapy in…
NCT00004412 · Susan P. Perrine, Other · Completed
Key facts
| NCT number | NCT00004412 |
|---|---|
| Title | Phase II Randomized Trial:Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers |
| Official title | Phase II Trial of Arginine Butyrate for Treatment of Refractory Leg Ulcers in Sickle Cell Disease or Beta Thalassemia |
| Lead sponsor | Susan P. Perrine, Other |
| Collaborators | Boston Medical Center University of Illinois at Chicago Icahn School of Medicine at Mount Sinai University of Tennessee Schneider Children's Medical Center, Israel |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Skin Ulcers, Sickle Cell Anemia |
| Intervention type | Drug, Other |
| Interventions | Arginine Butyrate, Standard local care dressing |
| Enrollment | 23 |
| Start date | Sep 1, 1997 |
| Primary completion | Dec 1, 2002 |
| Completion | Feb 1, 2005 |
| First posted | Oct 19, 1999 |
| Last update posted | Mar 31, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: